L

C

LINASSIER , Claude

Last name: LINASSIER

First name: Claude

August 2015 (v1)

Journal article

Metadata-only

Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model

Gravis, Gwenaelle Boher, Jean-Marie Fizazi, Karim

Background: The Glass model developed in 2003 uses prognostic factors for noncastrate metastatic prostate cancer (NCMPC) to define subgroups with good, intermediate, and poor prognosis.Objective: To validate NCMPC risk groups in a more recently diagnosed population and to develop a more sensitive prognostic model.Design, setting, and...

Uploaded on: December 4, 2022
July 2015 (v1)

Journal article

Metadata-only

Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial

Fizazi, Karim Faivre, Laura Lesaunier, François

BACKGROUND:Early risk-stratified chemotherapy is a standard treatment for breast, colorectal, and lung cancers, but not for high-risk localised prostate cancer. Combined docetaxel and estramustine improves survival in patients with castration-resistant prostate cancer. We assessed the effects of combined docetaxel and estramustine on relapse in...

Uploaded on: December 4, 2022